SCHEMBL3345555

SCHEMBL3345555

CCCCCCCCCCC/C(O)=C/C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.56
PPARG P37231 7/20 0.56
PPARD Q03181 7/20 0.56
PPARA Q07869 7/20 0.56
HDAC11 Q96DB2 5/20 0.56
TSHR P16473 4/20 0.56
PTPN1 P18031 3/20 0.56
FABP4 P15090 3/20 0.56
ALDH1A1 P00352 2/20 0.56
TLR2 O60603 2/20 0.56
TDP1 Q9NUW8 2/20 0.56
ALOX15 P16050 2/20 0.56
HSD17B10 Q99714 2/20 0.56
SLC22A6 Q4U2R8 1/20 0.56
SLC22A8 Q8TCC7 1/20 0.56
MEN1 O00255 1/20 0.56
ESR1 P03372 1/20 0.56
PDE4A P27815 1/20 0.56
KMT2A Q03164 1/20 0.56
PDE3A Q14432 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3345559 1.00 GPR84 (0.56) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL8088535 1.00 GPR84 (0.56) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL5000537 1.00 GPR84 (0.56) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL15516842 1.00 GPR84 (0.56) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL8075409 1.00 GPR84 (0.56) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL726950 1.00 GPR84 (0.56) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL25356914 1.00 GPR84 (0.56) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL726951 1.00 GPR84 (0.56) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL3349403 1.00 GPR84 (0.56) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL3349408 1.00 GPR84 (0.56) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260076887-A1 PERSONAL CARE COMPOSITIONS CONTAINING TAILORED MONOLIPID-RHAMNOLIPIDS AND SULFATE-FREE SURFACTANTS PROCTER & GAMBLE (US) 2026-03-19 US claimed
US-20260000078-A1 ANTI-MICROBIAL SYSTEM PROCTER & GAMBLE (US) 2026-01-01 US claimed
US-20260000596-A1 SEMI-SYNTHETIC RHAMNOLIPIDS PROCTER & GAMBLE (US) 2026-01-01 US claimed
US-20250268805-A1 PERSONAL CARE COMPOSITIONS CONTAINING TAILORED MONOLIPID-RHAMNOLIPIDS AND SULFATE-FREE SURFACTANTS THE PROCTER & GAMBLE COMPANY 2025-08-28 US claimed
US-20250268806-A1 PERSONAL CARE COMPOSITION WITH A MULTIFUNCTIONAL INGREDIENT THE PROCTER & GAMBLE COMPANY 2025-08-28 US claimed
EP-3320088-A1 EXTRACELLULAR PRODUCTION OF DESIGNER HYDROXYALKANOYLOXY ALKANOIC ACIDS WITH RECOMBINANT BACTERIA Rheinisch-Westfälische Technische Hochschule Aachen (RWTH) (DE) 2018-05-16 EP claimed
US-20180112241-A1 EXTRACELLULAR PRODUCTION OF DESIGNER HYDROXYALKANOYLOXY ALKANOIC ACIDS WITH RECOMBINANT BACTERIA RHEINISCH-WESTFAELISCHE TECHNISCHE HOCHSCHULE AACHEN (DE) 2018-04-26 US claimed
US-9854799-B2 Means and methods for rhamnolipid production AMLIKA MERCANTILE PRIVATE LIMITED (IN) 2018-01-02 US claimed
US-9714341-B2 Biodegradable polyester-based blends WASHINGTON STATE UNIVERSITY (US) 2017-07-25 US claimed
WO-2017006252-A1 EXTRACELLULAR PRODUCTION OF DESIGNER HYDROXYALKANOYLOXY ALKANOIC ACIDS WITH RECOMBINANT BACTERIA RHEINISCH-WESTFAELISCHE TECHNISCHE HOCHSCHULE AACHEN (RWTH) (DE) 2017-01-12 WO claimed
US-20160053112-A1 BIODEGRADABLE POLYESTER-BASED BLENDS EMPIRE TECHNOLOGY DEVELOPMENT LLC 2016-02-25 US claimed
WO-2014149024-A1 BIODEGRADABLE POLYESTER-BASED BLENDS WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION (US) 2014-09-25 WO claimed
US-20140235561-A1 MEANS AND METHODS FOR RHAMNOLIPID PRODUCTION AMLIKA MERCANTILE PRIVATE LIMITED (IN) 2014-08-21 US claimed
EP-2758526-A1 MEANS AND METHODS FOR RHAMNOLIPID PRODUCTION Heinrich-Heine-Universität (DE) 2014-07-30 EP claimed
WO-2014039940-A1 CELLS AND METHODS FOR THE PRODUCTION OF RHAMNOLIPIDS LOGOS TECHNOLOGIES LLC (US) 2014-03-13 WO claimed
WO-2013041670-A1 MEANS AND METHODS FOR RHAMNOLIPID PRODUCTION HEINRICH-HEINE-UNIVERSITAET (DE) 2013-03-28 WO claimed
EP-2573172-A1 Means and methods for rhamnolipid production Heinrich-Heine-Universität Düsseldorf (DE) 2013-03-27 EP claimed
WO-2010044118-A1 PRODUCTION OF BIODEGRADABLE PLASTICS FROM BRASSICA CARINATA OIL WITH HIGH CONTENT OF ERUCIC ACID AND FROM VERY LONG CHAIN FATTY ACIDS BALLISTRERI ALBERTO (IT) 2010-04-22 WO claimed
EP-1044278-A1 BIOSYNTHESIS OF MEDIUM CHAIN LENGTH POLYHYDROXYALKANOATES MONSANTO COMPANY (US) 2000-10-18 EP claimed
WO-1999035278-A1 BIOSYNTHESIS OF MEDIUM CHAIN LENGTH POLYHYDROXYALKANOATES MONSANTO COMPANY (US) 1999-07-15 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250268805-A1 PERSONAL CARE COMPOSITIONS CONTAINING TAILORED MONOLIPID-RHAMNOLIPIDS AND SULFATE-FREE SURFACTANTS SMURF1, CUTA, SMURF2 GPR84 522/4885PPARG 1306/4885PPARD 687/4885
US-20260000596-A1 SEMI-SYNTHETIC RHAMNOLIPIDS LPAR3, LPAR1, LPAR2 GPR84 442/4885PPARG 2145/4885PPARD 1970/4885
US-20260000078-A1 ANTI-MICROBIAL SYSTEM MGLL, LIPA, LIPC GPR84 3670/4885PPARG 2517/4885PPARD 1447/4885
US-20260076887-A1 PERSONAL CARE COMPOSITIONS CONTAINING TAILORED MONOLIPID-RHAMNOLIPIDS AND SULFATE-FREE SURFACTANTS CUTA, PHOSPHO1, MGLL GPR84 1057/4885PPARG 2937/4885PPARD 1256/4885
US-20250268806-A1 PERSONAL CARE COMPOSITION WITH A MULTIFUNCTIONAL INGREDIENT CUTA, LRAT, MGLL GPR84 963/4885PPARG 1481/4885PPARD 1510/4885
US-20140235561-A1 MEANS AND METHODS FOR RHAMNOLIPID PRODUCTION MRPL21, CMBL, MGLL GPR84 3386/4885PPARG 3369/4885PPARD 3680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.